Crestline Management, LP Immunocore Holdings PLC Transaction History
Crestline Management, LP
- $2.93 Billion
- Q4 2024
A detailed history of Crestline Management, LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Crestline Management, LP holds 24,960 shares of IMCR stock, worth $745,555. This represents 0.03% of its overall portfolio holdings.
Number of Shares
24,960Holding current value
$745,555% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding IMCR
# of Institutions
125Shares Held
42.5MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$200 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$198 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$145 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$79.7 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$65.3 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.31B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...